Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
GC, Gastric Adenocarcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
Apoptosis↑, TumCP↓, MAPK↓, PI3K↓, Akt↓, NF-kB↓, AntiCan↑, ChemoSen↑, TumCCA↑, Apoptosis↑, BioAv↑, selectivity↑, TGF-β↓, ROS↑, DNAdam↑, p‑P53↑, P21↑, cycD1/CCND1↓, cycE/CCNE↓, CDK4↓, CDK6↓, MMP↓, NF-kB↑, BAX↑, Bcl-2↓, ER Stress↑, Casp↑, AIF↑, Fas↑, Casp8↑, Cyt‑c↑, cl‑PARP↑, Ca+2↑, *NRF2↑, *chemoP↑, *GutMicro↑, CycB/CCNB1↑, H2S↑, HIF-1↓, RadioS↑,
Ferroptosis↑, NRF2↓, HO-1↓, PI3K↓, Akt↓, TumMeta↓,
AntiCan↑, Apoptosis↑, TumCP↓, TumMeta↓, BAX↑, TumAuto↑, ROS↑, NRF2↝, PI3K↓, Akt↓, NF-kB↓, TGF-β↓, SMAD4↓, GPx4↓, MMP↓, *HO-1↑, *GSTs↑, *antiOx↑, *AntiTum↑, *NRF2↑, ChemoSen↑, Akt↓, mTOR↓, FAK↓, Ki-67↓,
Hif1a↓, HK2↓, LDHA↓, PDK1↓, p‑Akt↓, PTEN↑, GlucoseCon↓, lactateProd↓, Glycolysis↓,
ChemoSen↑, HK2↓, LDHA↓, PDK1↓, Akt↓, PTEN↑, Hif1a↓, Glycolysis↓, ROS↑, CHOP↑,
| - |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
GC, |
BGC-823 |
|
|
|
tumCV↓, MDR1↓, ChemoSen↑, PI3K↓, Akt↓, mTOR↓,
| - |
vitro+vivo, |
GC, |
BGC-823 |
|
|
|
TumCP↓, TumCG↓, PTEN↑, BAX↑, Bcl-2↓, p‑Akt↓, COX2↓,
| - |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
GC, |
BGC-823 |
|
|
|
TumCP↓, Apoptosis↑, TumAuto↑, P53↑, PI3K↓, P21↑, p‑Akt↓, p‑mTOR↓, Bcl-2↓, Bcl-xL↓, LC3I↓, BAX↑, Beclin-1↑, cl‑Casp3↑, cl‑PARP↑, LC3II↑, ATG3↑, ATG5↑,
Casp9↑, Casp3↑, Hif1a↓, VEGF↓, TumCCA↑, TumCG↓, DNAdam↑, p‑Akt↓,
STAT3↓, TumCP↓, Apoptosis↑, NF-kB↓, EMT↓, RadioS↑, antiOx↑, COX1↓, COX2↓, cMyc↓, Snail↓, Twist↓, MMP2↓, P90RSK↓, CDK8↓, PI3K↓, Akt↓, TumCCA↑, Casp8↑, PCNA↓, TGF-β↓, Shh↓, NOTCH↓, IL6↓, ALAT↓, ALP↓, AST↓, VEGF↓, P21↑, *toxicity∅, *Inflam↓, *cardioP↑, *neuroP↑, *hepatoP↑, ROS↑, *NRF2↓, *GSH↑,
TumCP↓, TumCI↓, Apoptosis↑, PI3K/Akt↓, Akt↓, p‑mTOR↓, cycD1/CCND1↓, MMP2↓, MMP9↓, BAX↑, Bcl-2↓,
| - |
in-vitro, |
GC, |
AGS |
|
|
|
- |
in-vitro, |
GC, |
NCI-N87 |
|
|
|
- |
in-vitro, |
BC, |
MGC803 |
|
|
|
- |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
TumCP↓, Apoptosis↑, TumCI↓, TumCMig↓, HER2/EBBR2↓, TumCCA↑, PI3K↓, Akt↓, MMP9↓, P21↑,
AntiCan↑, DNAdam↑, Apoptosis↑, TumCCA↑, Bax:Bcl2↑, MMP↓, Casp3↑, PI3K↓, Akt↓,
tumCV↓, TumCI↓, TumCMig↓, Apoptosis↑, PARP↓, PI3K↓, Akt↓, Hif1a↓, PKM2↓, COX2↓,
| - |
in-vitro, |
GC, |
SNU16 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
TumCP↓, Apoptosis↑, BAX↑, BAD↑, Cyt‑c↑, cl‑PARP↑, cl‑Casp3↑, Bcl-2↓, Bcl-xL↓, p‑PI3K↓, p‑Akt↓, Ki-67↓, toxicity↓, RadioS↑,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Ferroptosis↑, 1, GPx4↓, 1, HO-1↓, 1, NRF2↓, 1, NRF2↝, 1, ROS↑, 4,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, MMP↓, 3,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1, cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 2, H2S↑, 1, HK2↓, 2, lactateProd↓, 1, LDHA↓, 2, PDK1↓, 2, PI3K/Akt↓, 1, PKM2↓, 1,
Cell Death ⓘ
Akt↓, 11, p‑Akt↓, 5, Apoptosis↑, 10, BAD↑, 1, BAX↑, 6, Bax:Bcl2↑, 1, Bcl-2↓, 5, Bcl-xL↓, 2, Casp↑, 1, Casp3↑, 2, cl‑Casp3↑, 2, Casp8↑, 2, Casp9↑, 1, Cyt‑c↑, 2, Fas↑, 1, Ferroptosis↑, 1, MAPK↓, 1,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 2,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
ATG3↑, 1, ATG5↑, 1, Beclin-1↑, 1, LC3I↓, 1, LC3II↑, 1, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 3, P53↑, 1, p‑P53↑, 1, PARP↓, 1, cl‑PARP↑, 3, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, CycB/CCNB1↑, 1, cycD1/CCND1↓, 2, cycE/CCNE↓, 1, P21↑, 4, TumCCA↑, 5,
Proliferation, Differentiation & Cell State ⓘ
CDK8↓, 1, EMT↓, 1, mTOR↓, 2, p‑mTOR↓, 2, NOTCH↓, 1, P90RSK↓, 1, PI3K↓, 9, p‑PI3K↓, 1, PTEN↑, 3, Shh↓, 1, STAT3↓, 1, TumCG↓, 2,
Migration ⓘ
Ca+2↑, 1, FAK↓, 1, Ki-67↓, 2, MMP2↓, 2, MMP9↓, 2, SMAD4↓, 1, Snail↓, 1, TGF-β↓, 3, TumCI↓, 3, TumCMig↓, 2, TumCP↓, 8, TumMeta↓, 2, Twist↓, 1,
Angiogenesis & Vasculature ⓘ
HIF-1↓, 1, Hif1a↓, 4, VEGF↓, 2,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 3, IL6↓, 1, NF-kB↓, 3, NF-kB↑, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 4, MDR1↓, 1, RadioS↑, 3, selectivity↑, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1, ALP↓, 1, AST↓, 1, HER2/EBBR2↓, 1, IL6↓, 1, Ki-67↓, 2,
Functional Outcomes ⓘ
AntiCan↑, 3, toxicity↓, 1,
Total Targets: 106
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GSH↑, 1, GSTs↑, 1, HO-1↑, 1, NRF2↓, 1, NRF2↑, 2,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Clinical Biomarkers ⓘ
GutMicro↑, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, cardioP↑, 1, chemoP↑, 1, hepatoP↑, 1, neuroP↑, 1, toxicity∅, 1,
Total Targets: 14
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:28 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page